Facebook
Twitter
LinkedIn
ForwardPULSE: Optimizing Post-Transplant Care: Harnessing GLP-1s in Kidney Transplant Recipients_enduring
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Kidney transplant recipients often face complex challenges related to metabolic health, including increased risk of diabetes and cardiovascular disease, which can significantly impact graft survival and overall outcomes. GLP-1 receptor agonists represent a promising therapeutic avenue for addressing these risks. By highlighting the latest evidence and practical considerations surrounding the use of GLP-1s in this patient population, this presentation aims to empower healthcare providers with the knowledge and tools to optimize post-transplant care.
Target Audience
Pharmacist
Learning Objectives
Identify the physiological mechanisms of GLP-1 receptor agonists and their relevance in post-transplant management.
Identify the challenges and unique considerations in managing metabolic health in kidney transplant recipients.
Discuss the evidence supporting the use of GLP-1 receptor agonists in improving metabolic parameters and renal outcomes post-kidney transplantation
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide (2) (1).pptx | 467.11 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Kidney transplant recipients often face complex challenges related to metabolic health, including increased risk of diabetes and cardiovascular disease, which can significantly impact graft survival and overall outcomes. GLP-1 receptor agonists represent a promising therapeutic avenue for addressing these risks. By highlighting the latest evidence and practical considerations surrounding the use of GLP-1s in this patient population, this presentation aims to empower healthcare providers with the knowledge and tools to optimize post-transplant care.
Jelena Lakic, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.